A new trading day began on Friday, with Atricure Inc (NASDAQ: ATRC) stock price down -7.39% from the previous day of trading, before settling in for the closing price of $34.37. ATRC’s price has ranged from $18.94 to $43.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 16.03% over the last five years. Meanwhile, its annual earnings per share averaged 27.64%. With a float of $47.13 million, this company’s outstanding shares have now reached $48.87 million.
The firm has a total of 1300 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.37%, operating margin of -8.6%, and the pretax margin is -9.39%.
Atricure Inc (ATRC) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Atricure Inc is 3.58%, while institutional ownership is 96.09%. The most recent insider transaction that took place on Mar 05 ’25, was worth 232,532. In this transaction Director of this company sold 6,100 shares at a rate of $38.12, taking the stock ownership to the 17,828 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Director proposed sale 6,100 for $38.04, making the entire transaction worth $232,044.
Atricure Inc (ATRC) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 64.76% during the next five years compared to -0.33% drop over the previous five years of trading.
Atricure Inc (NASDAQ: ATRC) Trading Performance Indicators
Here are Atricure Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Atricure Inc (ATRC)
Analysing the last 5-days average volume posted by the [Atricure Inc, ATRC], we can find that recorded value of 0.73 million was better than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 38.30%. Additionally, its Average True Range was 1.82.
During the past 100 days, Atricure Inc’s (ATRC) raw stochastic average was set at 16.75%, which indicates a significant increase from 7.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.55% in the past 14 days, which was higher than the 46.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.90, while its 200-day Moving Average is $30.58. Now, the first resistance to watch is $33.46. This is followed by the second major resistance level at $35.09. The third major resistance level sits at $36.06. If the price goes on to break the first support level at $30.86, it is likely to go to the next support level at $29.89. Should the price break the second support level, the third support level stands at $28.26.
Atricure Inc (NASDAQ: ATRC) Key Stats
With a market capitalization of 1.56 billion, the company has a total of 48,880K Shares Outstanding. Currently, annual sales are 465,310 K while annual income is -44,700 K. The company’s previous quarter sales were 124,280 K while its latest quarter income was -15,570 K.